Levels of biological markers of nitric oxide in serum of patients with squamous cell carcinoma of the oral cavity

International Journal of Oral Science

Volumn 5, Issue 3, 2013, Pages 141-145

  Ratajczak Wrona, Wioletta ^a   Jablonska, Ewa ^a   Antonowicz, Bozena ^a   Dziemianczyk, Dorota ^a   Grabowska, Stanislawa Zyta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

malonyldialdehyde; nitric oxide; nitrotyrosine; squamous cell carcinoma of the oral cavity

Indexed keywords

3 NITROTYROSINE; 3-NITROTYROSINE; DRUG DERIVATIVE; MALONALDEHYDE; NITRIC OXIDE; TYROSINE;

AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; METABOLISM; MOUTH TUMOR; NONPARAMETRIC TEST; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MOUTH NEOPLASMS; NITRIC OXIDE; STATISTICS, NONPARAMETRIC; TYROSINE;

EID: 84884583069     PISSN: 16742818     EISSN: 20493169     Source Type: Journal    
DOI: 10.1038/ijos.2013.59     Document Type: Article

References (41)

1. Chen AY, Myers JN. Cancer of the oral cavity. Dis Mon 2001; 47(7): 275-361.
2. Massano J, Regateiro FS, Januario G et al. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102(1): 67-76.
3. Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995; 9(13): 1319-1330.
4. Xu W, Liu LZ, Loizidou M et al. The role of nitric oxide in cancer. Cell Res 2002; 12(5/6): 311-320.
5. Ohashi M, Iwase M, Nagumo M. Elevated production of salivary nitric oxide in oral mucosal diseases. J Oral Pathol Med 1999; 28(8): 355-359.
6. Sumitani K, Kamijo R, Nagumo M. Cytotoxic effect of sodium nitroprusside on cancer cells: involvement of apoptosis and suppression of c-myc and c-myb proto-oncogene expression. Anticancer Res 1997; 17(2A): 865-871.
7. Shang ZJ, Li JR, Li ZB. Effects of exogenous nitric oxide on oral squamous cell carcinoma: an in vitro study. J Oral Maxillofac Surg 2002; 60(8): 905-911.
8. Sandau KB, Fandrey J, Brüne B. Accumulation of HIF-1a under the influence of nitric oxide. Blood 2001; 97(4): 1009-1015.
9. Vaupel P. The role of hypoxia-induced factors in tumor progression. Oncologist 2004; 9(5): 10-17.
10. Koukourakis MI, Giatromanolaki A, Sivridis E et al. Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell headand-neck cancer. Int J Radiat Oncol Biol Phys 2002; 53(5): 1192-1202.
11. Dix TA, Aikens J. Mechanisms and biological relevance of lipid peroxidation initiation. Chem Res Toxicol 1993; 6(1): 2-18.
12. Kourie JI. Interaction of reactive oxygen species with ion transport mechanisms. Am J Physiol 1998; 275(1): 1-24.
13. McConnell EJ, Bittelmeyer AM, Raess BU. Irreversible inhibition of plasma membrane (Ca211Mg21)-ATPase and Ca21 transport by 4-OH-2,3-trans-nonenal. Arch Biochem Biophys 1999; 361(2): 252-256.
14. Tyurina YY, Shvedova AA, Kawai K et al. Phospholipid signaling in apoptosis: peroxidation and externalization of phosphatidylserine. Toxicology 2000; 148(2/3): 93-101.
15. Hanafy KA, Krumenacker JS, Murad F. NO, nitrotyrosine, and cyclic GMP in signal transduction. Med Sci Monit 2001; 7(4): 801-819.
16. Hughes MN. Relationships between nitric oxide, nitroxyl ion, nitrosonium cation and peroxynitrite. Biochim Biophys Acta 1999; 1411(2/3): 263-272.
17. American Joint Committee on Cancer. Manual for Staging of Cancer. 4th ed. Philadelphia: JB Lippincott, 1992.
18. Jablonska E, Kiersnowska-Rogowska B, Ratajczak W et al. Reactive oxygen and nitrogen species in the course of B-CLL. Adv Med Sci 2007; 52(1): 154-158.
19. Singh S, Gupta AK. Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies. Cancer Chemother Pharmacol 2011; 67(6): 1211-1224.
20. Wink DA, Mitchell JB. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 1998; 25(4/5): 434-456.
21. Beevi SS, Rasheed AM, Geetha A. Evaluation of oxidative stress and nitric oxide levels in patients with oral cavity cancer. Jpn J Clin Oncol 2004; 34(7): 379-385.
22. Rasheed MH, Beevi SS, Geetha A. Enhanced lipid peroxidation and nitric oxide products with deranged antioxidant status in patients with head and neck squamous cell carcinoma. Oral Oncol 2007; 43(4): 333-338.
23. Gokul S, Patil VS, Jailkhani R et al. Oxidant-antioxidant status in blood and tumor tissue of oral squamous cell carcinoma patients. Oral Dis 2010; 16(1): 29-33.
24. Jablonska E, Puzewska W, Charkiewicz M. Effect of IL-18 on leukocyte expression of iNOS and phospho-IkappaB in patients with squamous cell carcinoma of the oral cavity. Neoplasma 2006; 53(3): 200-205.
25. Gavilanes J, Moro MA, Lizasoain I et al. Nitric oxide synthase activity in human squamous cell carcinoma of the head and neck. Laryngoscope 1999; 109(1): 148-152.
26. Brennan PA, Thomas GJ, Langdon JD. The role of nitric oxide in oral diseases. Arch Oral Biol 2003; 48(2): 93-100.
27. Connelly ST, Macabeo-Ong M, Dekker N et al. Increased nitric oxide levels and iNOS over-expression in oral squamous cell carcinoma. Oral Oncol 2005; 41(3): 261-267.
28. Thomsen LL, Scott JM, Topley P et al. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400 w, a novel inhibitor. Cancer Res 1997; 57(1): 3300-3304.
29. Ambs S, Hussain SP, Harris CC. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J 1997; 11(6): 443-448.
30. Gallo O, Masini E, Morbidelli L et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 1998; 90(8): 587-596.
31. Morbidelli L, Chang CH, Douglas JG et al. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 1996; 170(1 Pt 2): 411-415.
32. Kawamata H, Uchida D, Hamano H et al. Active-MMP2 in cancer cell nests of oral cancer patients: correlation with lymph node metastasis. Int J Oncol 1998; 13(4): 699-704.
33. Kurahara S, ShinoharaM, Ikebe T et al. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 1999; 21(7): 627-638.
34. Maeda H, Noguchi Y, Sato K et al. Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn J Cancer Res 1994; 85(4): 331-334.
35. Przybyszewski W, Kasperczyk J, Stoklosa Ket al. [DNA damage induced by products of lipid peroxidation.] Post Hig Med Dosw 2005; 59(17): 75-81. Polish.
36. Torun M, Yardim S, Gonenc A et al. Serum beta-carotene, vitamin E, vitamin C and malondialdehyde levels in several types of cancer. J Clin Pharm Ther 1995; 20(5): 259-263.
37. Sabitha KE, Shyamaladevi CS. Oxidant and antioxidant activity changes in patients with oral cancer and treated with radiotherapy. Oral Oncol 1999; 35(3): 273-277.
38. Korde SD, Basak A, ChaudharyMet al. Enhanced nitrosative and oxidative stress with decreased total antioxidant capacity in patientswith oral precancer and oral squamous cell carcinoma. Oncology 2011; 80(5/6): 382-389.
39. Broncel M, Balcerak M, Ba a A et al. [The erythrocyte membrane structure in patients with mixed hyperlipidemia.] Wiad Lek 2007; 60(1/2): 4-9. Polish.
40. Yeo WS, Lee SJ, Lee JR et al. Nitrosative protein tyrosine modifications: biochemistry and functional significance. J Biochem Mol Biol 2008; 41(3): 194-203.
41. Mantovani A, Allavena P, Sica A et al. Cancer-related inflammation. Nature 2008; 454(7221): 436-444.